Case Study: The Value of Independent Quality Oversight for Sponsors

As the FDA is applying increasing pressure on sponsors to validate the work of their CROs, the need for independent quality oversight has become a critical element of the clinical trial process. Beaufort is the first CRO to offer independent quality oversight services to help sponsors ensure CRO’s are performing according to expectations and commitments as mandated by the FDA and other regulatory bodies.

Beaufort’s comprehensive approach to quality oversight is based on developing a QO plan that helps maximize CRO performance and identifies opportunities for early process improvement to help prevent delays and save cost.

Read this Case Study to see how Beaufort helped a global pharmaceutical firm that needed in-process oversight of its CROs for a pivotal Phase III trial.

The Value of Independent QO for Sponsors

Date posted: October 16, 2017

Categories: Press Releases and Articles